Valuation: Uscom Limited

Market Cap 3.12M 2.21M 1.91M 1.8M 1.64M 3.08M 212M 21.11M 8.27M 106M 8.32M 8.13M 354M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.14M 2.71M 2.55M 2.32M 4.36M 300M 29.88M 11.71M 150M 11.77M 11.52M 500M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.011
0.01
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.15
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 07/03/2011
Corporate Secretary 66 24/05/2016
Corporate Officer/Principal - 28/05/2018
Director TitleAgeSince
Chairman - 01/11/2009
Director/Board Member 66 23/08/2018
Director/Board Member 62 16/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%+9.09%-76.92% 2.22M
+0.75%-2.21%+21.35%+11.13% 216B
-1.40%-3.34%-4.07%-20.25% 142B
+0.24%-1.76%-18.10%+37.85% 138B
-1.72%-0.99%-50.82%+0.99% 74.53B
+0.40%-2.59%+16.51%+19.13% 52.34B
+1.18%-0.33%-16.45%-13.29% 50.28B
+0.12%-0.29%+26.15%+24.99% 41.93B
-1.53%-2.80%+39.39%+49.41% 40.06B
+0.32%+0.30%-0.27%+6.74% 32.69B
Average +0.74%-0.47%+2.28%+3.98% 78.87B
Weighted average by Cap. -0.12%-1.16%+0.58%+10.65%

Financials

2024 2025
Net sales 3.73M 2.64M 2.28M 2.15M 1.95M 3.67M 253M 25.2M 9.88M 127M 9.93M 9.71M 422M 2.58M 1.83M 1.58M 1.49M 1.35M 2.54M 175M 17.44M 6.83M 87.67M 6.87M 6.72M 292M
Net income -2.07M -1.47M -1.27M -1.2M -1.09M -2.04M -141M -14.03M -5.5M -70.54M -5.53M -5.41M -235M -3.3M -2.34M -2.02M -1.9M -1.73M -3.26M -225M -22.34M -8.75M -112M -8.8M -8.61M -374M
Net Debt -1.53M -1.09M -938K -882K -802K -1.51M -104M -10.35M -4.06M -52.04M -4.08M -3.99M -173M 1.3M 920K 795K 748K 680K 1.28M 88.17M 8.77M 3.44M 44.1M 3.46M 3.38M 147M
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35